ArticleInternational urology and nephrology2020
Looking beyond hypogonadism: association between low testosterone and metabolic syndrome in men 20-59 years.
Article in International urology and nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 13 citations in OpenAlex.
- Research progress on multi-mechanism analysis and protection strategies of ovarian aging and fertility decline.Journal of ovarian research · 2026Review
- Obesity, type 2 diabetes, and testosterone in ageing men.Reviews in endocrine & metabolic disorders · 2022Review
- Reproductive axis ageing and fertility in men.Reviews in endocrine & metabolic disorders · 2022Review
- Role of sex hormone-binding globulin in the free hormone hypothesis and the relevance of free testosterone in androgen physiology.Cellular and molecular life sciences : CMLS · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeRates of low testosterone and metabolic syndrome are increasing among adult men in the United States. Both are associated with increased cardiovascular mortality. This study aims to assess the association between low testosterone and metabolic syndrome with a population-based contemporary cohort of men aged 20-59 years.
methodsNational Health and Nutrition Examination Survey (NHANES) was used between the years of 2013 and 2016. Men aged 20-59 years with testosterone levels were included. Metabolic syndrome was defined by National Cholesterol Education Program (NCEP) Adult Treatment Protocol (ATP) III.
results24.4% of the cohort had low testosterone and 26.4% had metabolic syndrome. Univariate analysis revealed that men with low testosterone had a significantly higher prevalence of metabolic syndrome and metabolic syndrome criteria. Multivariable logistic regression revealed a significant association between low testosterone and a large waistline (Odds ratio (OR) 4.32), as well as low levels of high-density lipoprotein (HDL) (OR 1.67) among all men. Age-stratification revealed that men 20-39 years with a large waistline had an OR 6.43 for low testosterone.
conclusionNearly one quarter of men aged 20-59 years have low testosterone and metabolic syndrome. A large waistline increases the risk of low testosterone six-fold among young men.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.